You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 2, 2024

CLINICAL TRIALS PROFILE FOR SYMBYAX

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SYMBYAX

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00339079 ↗	Treatment of Hypochondriasis With CBT and/or SSRI	Completed	National Institute of Mental Health (NIMH)	Phase 1/Phase 2	2006-06-01	This study will compare the effectiveness of cognitive behavioral therapy, antidepressant medication, and a combination of the two for treating hypochondriasis.
NCT00339079 ↗	Treatment of Hypochondriasis With CBT and/or SSRI	Completed	Brigham and Women's Hospital	Phase 1/Phase 2	2006-06-01	This study will compare the effectiveness of cognitive behavioral therapy, antidepressant medication, and a combination of the two for treating hypochondriasis.
NCT00489593 ↗	Olanzapine in Patients With Advanced Cancer and Weight Loss	Completed	M.D. Anderson Cancer Center	Phase 1	2006-10-01	The goal of this clinical research study is to find the highest tolerable dose of the drug Olanzapine that can be given to patients with advanced cancer who are experiencing weight loss. Researchers want to find out if Olanzapine can help decrease weight loss in patients who are experiencing it because of cancer. How this drug affects performance status, cancer-related symptoms, and nutritional status in patients with advanced cancer will also be studied.
NCT00512291 ↗	Subcutaneous Olanzapine for Hyperactive or Mixed Delirium	Completed	M.D. Anderson Cancer Center	N/A	2005-06-01	The objective of this study is to determine the tolerability and safety of olanzapine administered as a subcutaneous injection to hospitalized patients with hyperactive or mixed delirium.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SYMBYAX

Condition Name

Chart
Table

Condition Name for SYMBYAX
Intervention	Trials
Advanced Cancer	2
Bipolar Depression	1
Hypochondriasis	1
Treatment Resistant Depression	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SYMBYAX
Intervention	Trials
Depression	2
Depressive Disorder	2
Body Weight	1
Hypochondriasis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SYMBYAX

Trials by Country

Map
Table

Trials by Country for SYMBYAX
Location	Trials
United States	24
Russian Federation	2
India	1
South Africa	1
Argentina	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SYMBYAX
Location	Trials
Texas	3
New York	2
Massachusetts	2
California	2
New Hampshire	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SYMBYAX

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SYMBYAX
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
Phase 1/Phase 2	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SYMBYAX
Clinical Trial Phase	Trials
Completed	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SYMBYAX

Sponsor Name

Chart
Table

Sponsor Name for SYMBYAX
Sponsor	Trials
M.D. Anderson Cancer Center	2
Eli Lilly and Company	2
National Institute of Mental Health (NIMH)	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SYMBYAX
Sponsor	Trials
Other	3
Industry	2
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.